2022. Genotype-Related Efficacy and Adverse Effects of Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder. Precision Medicine Communications. 2, 1 (Jun. 2022), 27–42. DOI:https://doi.org/10.55627/pmc.002.01.0044.